Home » Newsletters » BioWorld Science

BioWorld Science

May 29, 2019

View Archived Issues

Glial dysfunction is part of chemo brain

TLRs in DIO

"R-AI-diologist" can outperform radiologists in lung cancer screening

In infection, T cells are cachexia drivers

Food antigens drive IgE antibody elevation if no commensals present

SNG-001 for virus-induced exacerbations of lung disease

Enrollment opens in phase III study of HLX-10 in esophageal squamous cell carcinoma

Soligenix obtains support to study IDRs as bacterial threat countermeasures

Mutation in mevalonate kinase found in porokeratosis ptychotropica

Integral Molecular achieves milestone in Daiichi Sankyo immuno-oncology collaboration

Ziopharm and NCI sign T-cell technology licensing agreement

Bristol-Myers Squibb patents farnesoid X receptor agonists

ProMIS identifies antibody candidates that selectively bind toxic oligomers of tau for Alzheimer's

Researchers develop new murine model of dystrophic epidermolysis bullosa-squamous cell carcinoma

AbbVie and Calico Life Sciences jointly describe EIF2B activators

Idorsia prepares and tests antibacterial compounds

P2X3 and/or P2X2/3 receptor antagonists described in Beijing Tide Pharmaceutical patent

AiCuris reports agents for the treatment of HBV infections

In vivo antitumoral activity seen with mixture of cytokine-encoding mRNAs

FDA approves Revlimid with rituximab for previously treated FL and marginal zone lymphoma

Zynerba initiates phase II trial of Zygel to treat behavioral symptoms in 22q11.2 deletion syndrome

Eli Lilly divulges BTK inhibitors in recent patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...